RiboPro
PrivateLast Round
Series A
Oct 31, 2024
Total Funding Raised
$7.56M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
RiboPro operates in Healthcare & Life Sciences and is based in Oss. Its latest recorded funding round was a Series A round in October 2024.
RiboPro is a biotechnology company that provides messenger RNA (mRNA) and lipid nanoparticle (LNP) development and manufacturing services.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
RiboPro Comparables
Compare RiboPro with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Vernal Biosciences | 86% | |
| Helix Biotech | 84% | |
| eTheRNA | 84% |
For institutional investors. Book with your work email.
RiboPro Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Oct 31, 2024 | ||||
| Convertible Debt | Jan 10, 2024 | ||||
| Grant | Oct 27, 2021 | ||||
| Seed | Mar 22, 2021 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
RiboPro Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Mountainview Capital Partners | Series A |
| Rockstart | Seed, Series A |
| Brabantse Ontwikkelings Maatschappij | Convertible Debt, Seed, Series A |
| CEPI | Grant |
| Wellcome Leap | Grant |
| BOM Brabant Ventures | Series A |
| Vlasroot Group | Convertible Debt, Series A, Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 29, 2026
Grew 16% QoQ, from 37 to 43 employees.
- Jun 19, 2026
Monthly visitors increased 43% MoM, reaching 1.6K.
For institutional investors. Book with your work email.
RiboPro Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about RiboPro's valuation, stock price, and market status.
Is RiboPro a public or private company?
RiboPro is a private company.
What is the current stock price of RiboPro?
RiboPro is a private company, so its shares have no public market price. Caplight tracks RiboPro's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is RiboPro worth (valuation)?
Valuation information for RiboPro is not publicly available.
Can I buy RiboPro stock?
RiboPro shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was RiboPro's last funding round?
RiboPro's most recent funding round was Series A on October 31, 2024.
Who are the main investors in RiboPro?
Key investors in RiboPro include Wellcome Leap, Vlasroot Group.
Will RiboPro IPO soon?
No public IPO plans have been announced for RiboPro.
How can I track RiboPro secondary market activity?
Caplight tracks bids, offers, and trades in RiboPro's shares on secondary markets.